EUVIMEDEUVIMED entdecken
Crossref

Jinfeng pills ameliorate premature ovarian insufficiency induced by cyclophosphamide in rats and correlate to modulating IL-17A/IL-6 axis and MEK/ERK signals

Ying-Yi Hu, Rui-Hua Zhong, Xiang-Jie Guo, Guo-Ting Li, Jie-Yun Zhou, Wen-Jie Yang, Bing-Tao Ren, Yan Zhu

Journal of Ethnopharmacology · 2023-05 · 307 · 116242

DOI: 10.1016/j.jep.2023.116242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2023-05. Verfasst von Ying-Yi Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy School, Fudan University, Shanghai, 200032, China; Lab of Reproductive Pharmacology, NHC Key Lab of Reproduction Regulation, Shanghai Instit…. Hauptthemen laut MEDLINE: Menopause, Premature, Primary Ovarian Insufficiency. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 95 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Jinfeng Pill (JFP) is a classical Chinese medicine formula and composed of 9 herbs, including Epimedium brevicornu Maxim (Yinyanghuo), Cervus elaphus Linnaeus (Lurong), Panax ginseng C.A.Mey. (Renshen), Equus asinus (EJiao), Ligustrum lucidum W.T.Aiton (Nvzhenzi), Reynoutria multiflora (Thunb.) Moldenke (Heshouwu), Curculigo orchioides Gaertn (Xianmao), Neolitsea cassia (L.) Kosterm. (Rougui) and Leonurus japonicus Houtt. (Yimucao). The formula is clinically used to regulate menstrual cycle and alleviate polycystic ovarian syndrome due to its capabilities of ovulation induction. It is therefore presumed that JFP could be used for the therapy of premature ovarian insufficiency (POI) but the assumed efficacy has not been fully substantiated in experiment. AIM OF STUDY: To evaluate the effectiveness of JFP on cyclophosphamide (CTX)-induced POI and preliminarily explore its potential mechanisms of action. MATERIAL AND METHODS: An experimental rat model of POI was established by using CTX induction to assess the efficacy of JFP. The potential targets of action for JFP alleviating POI were predicted by the combination of network pharmacology and transcriptomics and finally validating by RT-qPCR and Western blot. RESULTS: JFP alleviated the damages of ovarian tissue induced by CTX in the rat model of POI via significantly decreasing serum levels of FSH and LH and the ratio of FSH/LH and increasing the levels of E2 and AMH, accompanied with promoting ovarian folliculogenesis and follicle maturity and reversing the depletion of follicle pool. With the analysis of network pharmacology, pathways in cancer, proteoglycans in cancer, PI3K-AKT, TNF and FoxO signaling pathways were predicted to be influenced by JFP. The results of RNA-seq further revealed that IL-17 signaling pathway was the most important pathway regulated by both CTX and JFP, following by transcriptional misregulation in cancer and proteoglycans in cancer. Combining the two analytical methods, JFP likely targeted genes associated with immune regulation, including COX-2, HSP90AA1, FOS, MMP3 and MAPK11 and pathways, including IL-17,Th17 cell differentiation and TNF signaling pathway. Finally, JFP was validated to regulate the mRNA expression of FOS, FOSB, FOSL1, MMP3, MMP13 and COX-2 and decrease the release of IL-17A and the protein expression of IL-6 and suppress the phosphorylation of MEK1/2 and ERK1/2 in CTX induced POI rats. CONCLUSION: Jinfeng Pill is effective to ameliorate the symptoms of POI induced by CTX in the model of rats and its action is likely associated with suppressing IL-17A/IL-6 axis and the activity of MEK1/2-ERK1/2 signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Menopause, PrematurePrimary Ovarian InsufficiencyAnimalsFemaleHumansRatsCyclooxygenase 2CyclophosphamideFollicle Stimulating HormoneInterleukin-17Interleukin-6Matrix Metalloproteinase 3Mitogen-Activated Protein Kinase KinasesPhosphatidylinositol 3-KinasesExtracellular Signal-Regulated MAP Kinases

Stichwörter der Autor:innen

IL-17/IL-6Jinfeng pillMEK/ ERKPremature ovarian insufficiencyTranscriptomics

Substanzen

Cyclooxygenase 2CyclophosphamideFollicle Stimulating HormoneInterleukin-17Interleukin-6Matrix Metalloproteinase 3Mitogen-Activated Protein Kinase KinasesPhosphatidylinositol 3-KinasesExtracellular Signal-Regulated MAP Kinases

Autor:innen und Institutionen

  • Pharmacy School, Fudan University, Shanghai, 200032, China; Lab of Reproductive Pharmacology, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Fudan University,…
  • Lab of Reproductive Pharmacology, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Fudan University, Shanghai, 200032, China.
  • Lab of Reproductive Pharmacology, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Fudan University, Shanghai, 200032, China. Electronic address: zhuyan@sippr.or…

Zitieren

APA

Hu, Y. Y., Zhong, R. H., Guo, X. J., Li, G. T., Zhou, J. Y., Yang, W. J., Ren, B. T., & Zhu, Y. (2023). Jinfeng pills ameliorate premature ovarian insufficiency induced by cyclophosphamide in rats and correlate to modulating IL-17A/IL-6 axis and MEK/ERK signals. Journal of Ethnopharmacology, 307, 116242. https://doi.org/10.1016/j.jep.2023.116242

Vancouver

Hu YY, Zhong RH, Guo XJ, Li GT, Zhou JY, Yang WJ, et al. Jinfeng pills ameliorate premature ovarian insufficiency induced by cyclophosphamide in rats and correlate to modulating IL-17A/IL-6 axis and MEK/ERK signals. Journal of Ethnopharmacology. 2023;307:116242. doi:10.1016/j.jep.2023.116242

BibTeX
@article{Hu2023,
  author = {Hu, Ying-Yi and Zhong, Rui-Hua and Guo, Xiang-Jie and Li, Guo-Ting and Zhou, Jie-Yun and Yang, Wen-Jie and Ren, Bing-Tao and Zhu, Yan},
  title = {Jinfeng pills ameliorate premature ovarian insufficiency induced by cyclophosphamide in rats and correlate to modulating IL-17A/IL-6 axis and MEK/ERK signals},
  journal = {Journal of Ethnopharmacology},
  year = {2023},
  volume = {307},
  pages = {116242},
  doi = {10.1016/j.jep.2023.116242}
}
Kostenlos starten →